MedPath

A prospective randomized controlled trial to investigate the effect of early administration of antibiotics for patients with suspected sepsis

Completed
Conditions
bloodpoisoning
sepsis
10004018
Registration Number
NL-OMON43665
Lead Sponsor
Vrije Universiteit Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
2800
Inclusion Criteria

1) in the history signs of an infection and a body temperature of > 38 degrees celcius or < 36 degrees celcius AND 2) at least of one the following criteria: A respiratory rate of > 20/min; A heart rate of > 90/min ;

Exclusion Criteria

- age <18 years
- known severe allergic reaction to ceftriaxone or to other beta-lactam antibiotics
- pregnancy
- Orthopaedic patients with prosthetic infections (e.g knee, hip)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>reduction of mortality in patients with sepsis </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>- Length of hospital stay , Length of ICU stay if applicable<br /><br>- Door to needle time in control group<br /><br>- Adverse events in the intervention group and the control group<br /><br>- Quality of life after one month after discharge from the hospital<br /><br>-- Number of blood cultures with Bacteria resistant to ceftriaxone<br /><br>- Hour of transfer to the intensive care, medium care or to a normal ward</p><br>
© Copyright 2025. All Rights Reserved by MedPath